{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:48:12Z","timestamp":1787028492800,"version":"build-2736575974"},"reference-count":132,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T00:00:00Z","timestamp":1670025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Ovarian cancer is one of the most lethal gynecological cancers worldwide. The poor prognosis of this malignancy is substantially attributed to the inadequate symptomatic biomarkers for early diagnosis and effective remedies to cure the disease against chemoresistance and metastasis. Ovarian cancer metastasis is often relatively passive, and the single clusters of ovarian cancer cells detached from the primary ovarian tumor are transcoelomic spread by the peritoneal fluid throughout the peritoneum cavity and omentum. Our earlier studies revealed that lipid-enriched ascitic\/omental microenvironment enforced metastatic ovarian cancer cells to undertake metabolic reprogramming and utilize free fatty acids as the main energy source for tumor progression and aggression. Intriguingly, cell susceptibility to ferroptosis has been tightly correlated with the dysregulated fatty acid metabolism (FAM), and enhanced iron uptake as the prominent features of ferroptosis are attributed to the strengthened lipid peroxidation and aberrant iron accumulation, suggesting that ferroptosis induction is a targetable vulnerability to prevent cancer metastasis. Therefore, the standpoints about tackling altered FAM in combination with ferroptosis initiation as a dual-targeted therapy against advanced ovarian cancer were highlighted herein. Furthermore, a discussion on the prospect and challenge of inducing ferroptosis as an innovative therapeutic approach for reversing remedial resistance in cancer interventions was included. It is hoped this proof-of-concept review will indicate appropriate directions for speeding up the translational application of ferroptosis-inducing compounds (FINs) to improve the efficacy of ovarian cancer treatment.<\/jats:p>","DOI":"10.3390\/ijms232315263","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T02:13:12Z","timestamp":1670206392000},"page":"15263","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["New Insights into Ferroptosis Initiating Therapies (FIT) by Targeting the Rewired Lipid Metabolism in Ovarian Cancer Peritoneal Metastases"],"prefix":"10.3390","volume":"23","author":[{"given":"Shijie","family":"Zhan","sequence":"first","affiliation":[{"name":"Department of Obstetrics & Gynaecology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0903-1164","authenticated-orcid":false,"given":"Mingo M. H.","family":"Yung","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynaecology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle K. Y.","family":"Siu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynaecology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peili","family":"Jiao","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynaecology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hextan Y. S.","family":"Ngan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynaecology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynaecology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"},{"name":"School of Medicine, The Chinese University of Hong Kong-Shenzhen, Shenzhen 518172, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4034-7469","authenticated-orcid":false,"given":"Karen K. L.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynaecology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: A review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"ref_2","unstructured":"(2022, January 12). Key Statistics for Ovarian Cancer, American Cancer Society\u2019s Cancer Statistics Center. Available online: https:\/\/www.cancer.org\/cancer\/ovarian-cancer\/about\/key-statistics.html#written_by."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1179299X19860815","DOI":"10.1177\/1179299X19860815","article-title":"Chemotherapy Resistance in Advanced Ovarian Cancer Patients","volume":"11","author":"Pokhriyal","year":"2019","journal-title":"Biomark. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1098-2388(200007\/08)19:1<3::AID-SSU2>3.0.CO;2-S","article-title":"Ovarian cancer: Epidemiology, biology, and prognostic factors","volume":"19","author":"Holschneider","year":"2000","journal-title":"Semin. Surg. Oncol."},{"key":"ref_5","unstructured":"(2022, January 04). Ovarian and Peritoneal Cancer, Centre for Health Protection, Department of Health, The Government of the Hong Kong Special Administrative Region, Available online: https:\/\/www.chp.gov.hk\/en\/healthtopics\/content\/25\/6625.html."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2217\/imt.11.20","article-title":"Immunity and immune suppression in human ovarian cancer","volume":"3","author":"Preston","year":"2011","journal-title":"Immunotherapy"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fonc.2013.00256","article-title":"Getting to know ovarian cancer ascites: Opportunities for targeted therapy-based translational research","volume":"3","author":"Ahmed","year":"2013","journal-title":"Front. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Yung, M.M.H., Siu, M.K.Y., Ngan, H.Y.S., Chan, D.W., and Chan, K.K.L. (2022). Orchestrated Action of AMPK Activation and Combined VEGF\/PD-1 Blockade with Lipid Metabolic Tunning as Multi-Target Therapeutics against Ovarian Cancers. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23126857"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.5301\/tj.5000571","article-title":"Histologic subtypes of ovarian carcinoma: Selected diagnostic and classification problems in Bulgaria: Is low hospital volume an issue?","volume":"103","author":"Ivanova","year":"2017","journal-title":"Tumori"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","article-title":"Ovarian cancer","volume":"2","author":"Matulonis","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"819183","DOI":"10.3389\/fbioe.2022.819183","article-title":"New Approaches and Biomarker Candidates for the Early Detection of Ovarian Cancer","volume":"10","author":"Hossain","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Rakina, M., Kazakova, A., Villert, A., Kolomiets, L., and Larionova, I. (2022). Spheroid Formation and Peritoneal Metastasis in Ovarian Cancer: The Role of Stromal and Immune Components. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23116215"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1002\/cncr.32004","article-title":"Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference","volume":"125","author":"Bast","year":"2019","journal-title":"Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1200\/JCO.2016.68.6907","article-title":"Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline","volume":"34","author":"Wright","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","article-title":"Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d\u2019Investigateurs Nationaux Pour les Etudes des Cancers de l\u2019Ovaire (GINECO)","volume":"115","author":"Reuss","year":"2009","journal-title":"Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Barbolina, M.V. (2018). Molecular Mechanisms Regulating Organ-Specific Metastases in Epithelial Ovarian Carcinoma. Cancers, 10.","DOI":"10.3390\/cancers10110444"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"m3773","DOI":"10.1136\/bmj.m3773","article-title":"Treatment of epithelial ovarian cancer","volume":"371","author":"Kuroki","year":"2020","journal-title":"BMJ"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2741\/3693","article-title":"Evidence for cancer stem cells contributing to the pathogenesis of ovarian cancer","volume":"16","author":"Curley","year":"2011","journal-title":"Front. Biosci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","article-title":"Identification and characterization of ovarian cancer-initiating cells from primary human tumors","volume":"68","author":"Zhang","year":"2008","journal-title":"Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","article-title":"Mechanisms of transcoelomic metastasis in ovarian cancer","volume":"7","author":"Tan","year":"2006","journal-title":"Lancet Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1080\/01635581.2016.1159702","article-title":"Malnutrition Identified by the Nutritional Risk Index and Poor Prognosis in Advanced Epithelial Ovarian Carcinoma","volume":"68","author":"Yim","year":"2016","journal-title":"Nutr. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/IGC.0b013e318256e4d3","article-title":"Noninvasive nutritional management of ovarian cancer patients: Beyond intestinal obstruction","volume":"22","author":"Balogun","year":"2012","journal-title":"Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc."},{"key":"ref_24","first-page":"1357","article-title":"Detachment from the primary site and suspension in ascites as the initial step in metabolic reprogramming and metastasis to the omentum in ovarian cancer","volume":"15","author":"Sato","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7603\/s40681-015-0019-4","article-title":"An overview of targeted cancer therapy","volume":"5","author":"Padma","year":"2015","journal-title":"Biomedicine"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-021-00572-w","article-title":"Small molecules in targeted cancer therapy: Advances, challenges, and future perspectives","volume":"6","author":"Zhong","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Zahavi, D., and Weiner, L. (2020). Monoclonal Antibodies in Cancer Therapy. Antibodies, 9.","DOI":"10.3390\/antib9030034"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Wiggans, A.J., Cass, G.K., Bryant, A., Lawrie, T.A., and Morrison, J. (2015). Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer. Cochrane Database Syst. Rev., CD007929.","DOI":"10.1002\/14651858.CD007929.pub3"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.mam.2013.01.006","article-title":"Therapeutic applications of PARP inhibitors: Anticancer therapy and beyond","volume":"34","author":"Curtin","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"ref_30","first-page":"EC43","article-title":"VEGF Expression to Support Targeted Therapy in Ovarian Surface Epithelial Neoplasms","volume":"11","author":"Mukherjee","year":"2017","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10555-014-9538-9","article-title":"Anti-vascular therapies in ovarian cancer: Moving beyond anti-VEGF approaches","volume":"34","author":"Choi","year":"2015","journal-title":"Cancer Metastasis Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1477-7827-1-66","article-title":"Chemoresistance in human ovarian cancer: The role of apoptotic regulators","volume":"1","author":"Fraser","year":"2003","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41698-018-0063-0","article-title":"Tumor evolution and chemoresistance in ovarian cancer","volume":"2","author":"Kim","year":"2018","journal-title":"NPJ Precis. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ccell.2021.12.009","article-title":"MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells","volume":"40","author":"Limagne","year":"2022","journal-title":"Cancer Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1177\/1534735415611747","article-title":"Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade","volume":"15","author":"Yung","year":"2015","journal-title":"Integr. Cancer Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"105157","DOI":"10.1016\/j.phrs.2020.105157","article-title":"MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis","volume":"161","author":"Chan","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/abbs\/gmv128","article-title":"Targeting AMPK signaling in combating ovarian cancers: Opportunities and challenges","volume":"48","author":"Yung","year":"2016","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc1123","article-title":"Ovarian cancer: Strategies for overcoming resistance to chemotherapy","volume":"3","author":"Agarwal","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1038\/s41598-021-85696-3","article-title":"Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands","volume":"11","author":"Verschueren","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.4161\/hv.20738","article-title":"Immunotherapy in ovarian cancer","volume":"8","author":"Corr","year":"2012","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer","volume":"348","author":"Zhang","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/15384047.2015.1040960","article-title":"Tumor infiltrating lymphocytes in ovarian cancer","volume":"16","author":"Santoiemma","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer","volume":"378","author":"Gandhi","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Yeldag, G., Rice, A., and Del Rio Hernandez, A. (2018). Chemoresistance and the Self-Maintaining Tumor Microenvironment. Cancers, 10.","DOI":"10.3390\/cancers10120471"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"100718","DOI":"10.1016\/j.drup.2020.100718","article-title":"Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies","volume":"53","author":"Melero","year":"2020","journal-title":"Drug Resist. Updat."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"690112","DOI":"10.3389\/fimmu.2021.690112","article-title":"Cancer Immunotherapies: From Efficacy to Resistance Mechanisms\u2014Not Only Checkpoint Matters","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/cas.12987","article-title":"Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer","volume":"107","author":"Kim","year":"2016","journal-title":"Cancer Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.bcp.2013.01.018","article-title":"Fibroblast-mediated drug resistance in cancer","volume":"85","author":"Paraiso","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1084\/jem.20180765","article-title":"Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer","volume":"216","author":"Gao","year":"2019","journal-title":"J. Exp. Med."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Lane, D., Matte, I., Garde-Granger, P., Laplante, C., Carignan, A., Rancourt, C., and Piche, A. (2015). Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1511-7"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ccr.2011.02.014","article-title":"SIRT3 opposes reprogramming of cancer cell metabolism through HIF1alpha destabilization","volume":"19","author":"Finley","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s42003-019-0508-1","article-title":"Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells","volume":"2","author":"Chen","year":"2019","journal-title":"Commun. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.7150\/thno.70194","article-title":"SCD1\/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells","volume":"12","author":"Xuan","year":"2022","journal-title":"Theranostics"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1515\/pp-2017-0020","article-title":"Definition and semantics: \u201cPeritoneal Carcinomatosis\u201d should be abandoned and replaced by \u201cPeritoneal Metastasis\u201d","volume":"2","author":"Reymond","year":"2017","journal-title":"Pleura Peritoneum"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1245\/s10434-009-0357-0","article-title":"Surgery for recurrent ovarian cancer: Role of peritoneal carcinomatosis: Exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis","volume":"16","author":"Harter","year":"2009","journal-title":"Ann. Surg. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.2353\/ajpath.2006.051222","article-title":"Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth","volume":"169","author":"Gerber","year":"2006","journal-title":"Am. J. Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e20192312","DOI":"10.1084\/jem.20192312","article-title":"The omentum, a niche for premetastatic ovarian cancer","volume":"217","author":"Ma","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_59","unstructured":"Evans, K.J. (2021, September 03). Solid Omental Tumors, Medscape. Available online: https:\/\/emedicine.medscape.com\/article\/193622-overview."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4240\/wjgs.v4.i4.87","article-title":"Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures","volume":"4","author":"Sangisetty","year":"2012","journal-title":"World J. Gastrointest. Surg."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.7150\/thno.22536","article-title":"GRO-alpha and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1\/NFkappaB signaling cascade","volume":"8","author":"Yung","year":"2018","journal-title":"Theranostics"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ajpath.2013.04.023","article-title":"Milky spots promote ovarian cancer metastatic colonization of peritoneal adipose in experimental models","volume":"183","author":"Clark","year":"2013","journal-title":"Am. J. Pathol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg Effect: How Does it Benefit Cancer Cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1038\/s41388-018-0637-x","article-title":"An evolving story of the metastatic voyage of ovarian cancer cells: Cellular and molecular orchestration of the adipose-rich metastatic microenvironment","volume":"38","author":"Motohara","year":"2019","journal-title":"Oncogene"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/path.4002","article-title":"The peritoneal tumour microenvironment of high-grade serous ovarian cancer","volume":"227","author":"Leinster","year":"2012","journal-title":"J. Pathol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Wang, X., Yung, M.M.H., Sharma, R., Chen, F., Poon, Y.T., Lam, W.Y., Li, B., Ngan, H.Y.S., Chan, K.K.L., and Chan, D.W. (2021). Epigenetic Silencing of miR-33b Promotes Peritoneal Metastases of Ovarian Cancer by Modulating the TAK1\/FASN\/CPT1A\/NF-kappaB Axis. Cancers, 13.","DOI":"10.3390\/cancers13194795"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10555-019-09794-5","article-title":"The Warburg metabolism fuels tumor metastasis","volume":"38","author":"Lu","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"C444","DOI":"10.1152\/ajpcell.00188.2015","article-title":"Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis","volume":"309","author":"Yeung","year":"2015","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.canlet.2018.08.006","article-title":"Fatty acid oxidation: An emerging facet of metabolic transformation in cancer","volume":"435","author":"Ma","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1007\/s12274-018-2092-y","article-title":"Scavenging of reactive oxygen and nitrogen species with nanomaterials","volume":"11","author":"Ferreira","year":"2018","journal-title":"Nano Res."},{"key":"ref_71","first-page":"137289","article-title":"Oxidative stress and lipid peroxidation products in cancer progression and therapy","volume":"2012","author":"Barrera","year":"2012","journal-title":"ISRN Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1152\/physrev.00040.2012","article-title":"Oxidative stress: An essential factor in the pathogenesis of gastrointestinal mucosal diseases","volume":"94","author":"Bhattacharyya","year":"2014","journal-title":"Physiol. Rev."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Singh, A., Kukreti, R., Saso, L., and Kukreti, S. (2019). Oxidative Stress: A Key Modulator in Neurodegenerative Diseases. Molecules, 24.","DOI":"10.3390\/molecules24081583"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41392-020-00216-5","article-title":"The interaction between ferroptosis and lipid metabolism in cancer","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: Past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nature05859","article-title":"RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels","volume":"447","author":"Yagoda","year":"2007","journal-title":"Nature"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/jcmm.13008","article-title":"Ferroptosis, a new form of cell death, and its relationships with tumourous diseases","volume":"21","author":"Yu","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.bbagen.2017.05.019","article-title":"Ferroptosis: Role of lipid peroxidation, iron and ferritinophagy","volume":"1861","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","article-title":"Mechanisms of ferroptosis","volume":"73","author":"Cao","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/cdd.2015.158","article-title":"Ferroptosis: Process and function","volume":"23","author":"Xie","year":"2016","journal-title":"Cell Death Differ."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","article-title":"Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells","volume":"15","author":"Yang","year":"2008","journal-title":"Chem. Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","article-title":"Ferroptosis, a new form of cell death: Opportunities and challenges in cancer","volume":"12","author":"Mou","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: A novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_85","first-page":"323","article-title":"Erastin\/sorafenib induces cisplatin-resistant non-small cell lung cancer cell ferroptosis through inhibition of the Nrf2\/xCT pathway","volume":"19","author":"Li","year":"2020","journal-title":"Oncol. Lett."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"101928","DOI":"10.1016\/j.redox.2021.101928","article-title":"PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer","volume":"42","author":"Hong","year":"2021","journal-title":"Redox Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"101413","DOI":"10.1016\/j.redox.2019.101413","article-title":"AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-Mediated redox homeostasis","volume":"30","author":"Chen","year":"2020","journal-title":"Redox Biol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nchembio.2238","article-title":"Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis","volume":"13","author":"Kagan","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1194\/jlr.M900081-JLR200","article-title":"15(S)-Lipoxygenase-1 associates with neutral lipid droplets in macrophage foam cells: Evidence of lipid droplet metabolism","volume":"50","author":"Weibel","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1021\/acscentsci.7b00589","article-title":"Resolving the Role of Lipoxygenases in the Initiation and Execution of Ferroptosis","volume":"4","author":"Shah","year":"2018","journal-title":"ACS Cent. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"765859","DOI":"10.3389\/fcell.2021.765859","article-title":"Ferroptosis: The Silver Lining of Cancer Therapy","volume":"9","author":"Tang","year":"2021","journal-title":"Front Cell. Dev. Biol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3389\/fphar.2017.00992","article-title":"The Role of Ferroptosis in Cancer Development and Treatment Response","volume":"8","author":"Lu","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41598-018-19213-4","article-title":"The ferroptosis inducer erastin irreversibly inhibits system xc- and synergizes with cisplatin to increase cisplatin\u2019s cytotoxicity in cancer cells","volume":"8","author":"Sato","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3389\/fonc.2019.01398","article-title":"Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer","volume":"9","author":"Zhou","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.imbio.2019.03.002","article-title":"Depletion of tumor-associated macrophages enhances the anti-tumor effect of docetaxel in a murine epithelial ovarian cancer","volume":"224","author":"Lu","year":"2019","journal-title":"Immunobiology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1158\/0008-5472.CAN-19-0369","article-title":"Stearoyl-CoA Desaturase 1 Protects Ovarian Cancer Cells from Ferroptotic Cell Death","volume":"79","author":"Tesfay","year":"2019","journal-title":"Cancer Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"571127","DOI":"10.3389\/fonc.2020.571127","article-title":"Ferroptosis in Cancer Treatment: Another Way to Rome","volume":"10","author":"Wu","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Sacco, A., Battaglia, A.M., Botta, C., Aversa, I., Mancuso, S., Costanzo, F., and Biamonte, F. (2021). Iron Metabolism in the Tumor Microenvironment-Implications for Anti-Cancer Immune Response. Cells, 10.","DOI":"10.3390\/cells10020303"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00508-015-0842-3","article-title":"Iron metabolism and iron supplementation in cancer patients","volume":"127","author":"Ludwig","year":"2015","journal-title":"Wien Klin. Wochenschr."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3389\/fonc.2018.00549","article-title":"Iron in the Tumor Microenvironment-Connecting the Dots","volume":"8","author":"Tymoszuk","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1038\/onc.2017.11","article-title":"Iron addiction: A novel therapeutic target in ovarian cancer","volume":"36","author":"Basuli","year":"2017","journal-title":"Oncogene"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s13046-019-1397-3","article-title":"Iron and leukemia: New insights for future treatments","volume":"38","author":"Wang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_104","first-page":"350","article-title":"Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil","volume":"10","author":"Wu","year":"2007","journal-title":"J. Pharm. Pharm. Sci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"630","DOI":"10.20892\/j.issn.2095-3941.2019.0158","article-title":"The crosstalk between autophagy and ferroptosis: What can we learn to target drug resistance in cancer?","volume":"16","author":"Zhou","year":"2019","journal-title":"Cancer Biol. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"626812","DOI":"10.3389\/fimmu.2020.626812","article-title":"Iron Metabolism in the Tumor Microenvironment: Contributions of Innate Immune Cells","volume":"11","author":"Liang","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41589-020-0472-6","article-title":"Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis","volume":"16","author":"Zou","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3389\/fimmu.2019.01347","article-title":"Iron-Dependent Trafficking of 5-Lipoxygenase and Impact on Human Macrophage Activation","volume":"10","author":"Dufrusine","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"E767","DOI":"10.1152\/ajpendo.00268.2013","article-title":"Role of stearoyl-CoA desaturase-1 in skeletal muscle function and metabolism","volume":"305","author":"Stamatikos","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Rockfield, S., Chhabra, R., Robertson, M., Rehman, N., Bisht, R., and Nanjundan, M. (2018). Links Between Iron and Lipids: Implications in Some Major Human Diseases. Pharmaceuticals, 11.","DOI":"10.3390\/ph11040113"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Pan, Q., Law, C.O.K., Yung, M.M.H., Han, K.C., Pon, Y.L., and Lau, T.C.K. (2018). Novel RNA aptamers targeting gastrointestinal cancer biomarkers CEA, CA50 and CA72-4 with superior affinity and specificity. PLoS ONE, 13.","DOI":"10.1101\/335620"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Wang, H., Yung, M.M.H., Ngan, H.Y.S., Chan, K.K.L., and Chan, D.W. (2021). The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126560"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40364-020-00229-w","article-title":"Novel insights on targeting ferroptosis in cancer therapy","volume":"8","author":"Zuo","year":"2020","journal-title":"Biomark. Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","article-title":"Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling","volume":"572","author":"Wu","year":"2019","journal-title":"Nature"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"629150","DOI":"10.3389\/fcell.2021.629150","article-title":"A Promising Future of Ferroptosis in Tumor Therapy","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"941618","DOI":"10.3389\/fonc.2022.941618","article-title":"Lipid metabolism in ferroptosis and ferroptosis-based cancer therapy","volume":"12","author":"Sun","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.cub.2018.05.094","article-title":"AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking System Xc(-) Activity","volume":"28","author":"Song","year":"2018","journal-title":"Curr. Biol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/ncb1426","article-title":"Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG","volume":"8","author":"Liang","year":"2006","journal-title":"Nat. Cell. Biol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/immuno2010014","article-title":"Ferroptosis in Cancer Immunotherapy\u2014Implications for Hepatocellular Carcinoma","volume":"2","author":"Kusnick","year":"2022","journal-title":"Immuno"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41422-019-0263-3","article-title":"The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression","volume":"30","author":"Lei","year":"2020","journal-title":"Cell Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3892\/ijo.2013.2063","article-title":"Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatin","volume":"43","author":"Chekhun","year":"2013","journal-title":"Int. J. Oncol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8(+) T cells regulate tumor ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.semcancer.2017.08.004","article-title":"Epigenetic drivers of tumourigenesis and cancer metastasis","volume":"51","author":"Chatterjee","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"17996","DOI":"10.1038\/s41598-019-54401-w","article-title":"Differential DNA methylation in high-grade serous ovarian cancer (HGSOC) is associated with tumor behavior","volume":"9","author":"Reyes","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1158\/1078-0432.CCR-13-2805","article-title":"Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine\/glutamate exchanger SLC7A11","volume":"20","author":"Drayton","year":"2014","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.febslet.2011.04.018","article-title":"MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11","volume":"585","author":"Liu","year":"2011","journal-title":"FEBS Lett."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1158\/0008-5472.CAN-17-3454","article-title":"A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53","volume":"78","author":"Mao","year":"2018","journal-title":"Cancer Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"34110","DOI":"10.1074\/jbc.M112.356717","article-title":"Micromanaging Iron Homeostasis: Hypoxia-inducible micro-RNA-210 suppresses iron homeostasis-related proteins","volume":"287","author":"Yoshioka","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00109-015-1362-3","article-title":"miR-20a regulates expression of the iron exporter ferroportin in lung cancer","volume":"94","author":"Babu","year":"2016","journal-title":"J. Mol. Med."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/19768354.2018.1512521","article-title":"Bromelain effectively suppresses Kras-mutant colorectal cancer by stimulating ferroptosis","volume":"22","author":"Park","year":"2018","journal-title":"Anim. Cells Syst."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.biocel.2013.04.029","article-title":"MiR-224 impairs adipocyte early differentiation and regulates fatty acid metabolism","volume":"45","author":"Peng","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bbrc.2014.02.068","article-title":"Involvement of cholesterol in hepatitis B virus X protein-induced abnormal lipid metabolism of hepatoma cells via up-regulating miR-205-targeted ACSL4","volume":"445","author":"Cui","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/23\/15263\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:33:35Z","timestamp":1760146415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/23\/15263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,3]]},"references-count":132,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["ijms232315263"],"URL":"https:\/\/doi.org\/10.3390\/ijms232315263","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,3]]}}}